SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 1,663.47 |
| Enterprise Value ($M) | 1,122.60 |
| Book Value ($M) | 707.50 |
| Book Value / Share | 8.93 |
| Price / Book | 2.35 |
| NCAV ($M) | 688.84 |
| NCAV / Share | 8.70 |
| Price / NCAV | 2.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 18.21 |
| Current Ratio | 18.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 753.24 |
| Assets | 771.90 |
| Liabilities | 64.40 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Opportunities Fund, L.P. | 2.90 | -33.33 | |
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 5.50 | -35.64 | |
| 13G/A | Paradigm Biocapital Advisors LP | 4.60 | -33.84 | |
| 13G/A | Perceptive Advisors Llc | 3.80 | -30.07 | |
| 13G/A | State Street Corp | 3.20 | -12.13 | |
| 13D/A | Fairmount Funds Management LLC | 17.95 | 11.46 | |
| 13G/A | Deep Track Capital, LP | 9.90 | 62.36 | |
| 13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
| 13G/A | Commodore Capital Lp | 3.70 | -4.76 | |
| 13G/A | Vanguard Group Inc | 5.71 | 41.89 | |
| 13G/A | BlackRock, Inc. | 6.50 | 24.08 | |
| 13G | Fmr Llc | 14.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 136,299 | 723,772 | 18.83 | |
| 172,075 | 722,913 | 23.80 | |
| 40,639 | 225,277 | 18.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BGLC – BioNexus Gene Lab Corp. | CELC – Celcuity Inc. |
| EXAS – Exact Sciences Corporation | MDXH – MDxHealth SA |
| PMD – Psychemedics Corporation |
Financial data and stock pages provided by
Fintel.io